Presentation Of New Preclinical Data On Apaziquone (E09) For The Treatment Of Invasive Bladder Cancer - Pharmaceuticals, Inc.

... SpectrumPharmaceuticals, Inc. (Nasdaq: SPPI) announced the presentation of newpreclinical data on Apaziquone at the 97th Annual Meeting of the AmericanAssociation for Cancer Research (AACR) in Washington, DC, earlier thismonth. A poster entitled "Analysis of NAD(P)H: quinine oxidoreductase-1(NQO1), Cytochrome P450 Oxidoreductase (P450R) and glucose transporter 1(Glut-1) protein expression suggests a possible role for E09 in thetreatment of invasive bladder cancer" (Abstract # 546, authors Roger M... click link for more info. ...